JP2023519363A5 - - Google Patents
Info
- Publication number
- JP2023519363A5 JP2023519363A5 JP2022558348A JP2022558348A JP2023519363A5 JP 2023519363 A5 JP2023519363 A5 JP 2023519363A5 JP 2022558348 A JP2022558348 A JP 2022558348A JP 2022558348 A JP2022558348 A JP 2022558348A JP 2023519363 A5 JP2023519363 A5 JP 2023519363A5
- Authority
- JP
- Japan
- Prior art keywords
- triazolo
- pyrimidine
- amino
- methyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062994954P | 2020-03-26 | 2020-03-26 | |
| US62/994,954 | 2020-03-26 | ||
| PCT/EP2021/057808 WO2021191380A1 (en) | 2020-03-26 | 2021-03-25 | Triazolone compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519363A JP2023519363A (ja) | 2023-05-10 |
| JP2023519363A5 true JP2023519363A5 (https=) | 2024-04-01 |
| JP7709454B2 JP7709454B2 (ja) | 2025-07-16 |
Family
ID=75302568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558348A Active JP7709454B2 (ja) | 2020-03-26 | 2021-03-25 | トリアゾロン化合物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12552799B2 (https=) |
| EP (1) | EP4126871B1 (https=) |
| JP (1) | JP7709454B2 (https=) |
| KR (1) | KR20230049580A (https=) |
| CN (1) | CN115867550B (https=) |
| AU (1) | AU2021241886A1 (https=) |
| CA (1) | CA3177057A1 (https=) |
| WO (1) | WO2021191380A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025512384A (ja) | 2022-04-13 | 2025-04-17 | ギリアード サイエンシーズ， インコーポレイテッド | Ｔｒｏｐ－２発現がんを治療するための併用療法 |
| WO2025137640A1 (en) | 2023-12-22 | 2025-06-26 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7452892B2 (en) | 2005-06-17 | 2008-11-18 | Bristol-Myers Squibb Company | Triazolopyrimidine cannabinoid receptor 1 antagonists |
| ATE457988T1 (de) | 2006-06-26 | 2010-03-15 | Schering Corp | A2a-adenosin-rezeptor-antagonisten |
| JP2011513417A (ja) * | 2008-03-04 | 2011-04-28 | シェーリング コーポレイション | アデノシンＡ２ａ受容体アンタゴニストとして使用するための１，２，４−トリアゾロ［４，３−ｃ］ピリミジン−３−オンおよびピラゾロ［４，３−ｅ］−１，２，４−トリアゾロ［４，３−ｃ］ピリミジン−３−オン化合物 |
| AU2011306358B2 (en) | 2010-09-24 | 2014-08-14 | Impetis Biosciences Ltd. | Fused tricyclic compounds as adenosine receptor antagonist |
| EP3277689B1 (en) | 2015-04-03 | 2019-09-04 | Incyte Corporation | Heterocyclic compounds as lsd1 inhibitors |
| AU2018233367B2 (en) | 2017-03-16 | 2021-08-12 | Jiangsu Hengrui Medicine Co., Ltd. | Heteroaryl[4,3-c]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereof |
| PL3611174T3 (pl) * | 2017-04-07 | 2022-08-08 | Medshine Discovery Inc. | Pochodne [1,2,4]triazolo[1,5-c]pirymidyny jako inhibitor receptora a2a |
| EP3774813A4 (en) * | 2018-04-08 | 2021-11-17 | BeiGene, Ltd. | PYRAZOLOTRIAZOLOPYRIMIDE DERIVATIVES AS A2A RECEPTOR ANTAGONIST |
| WO2020010197A1 (en) * | 2018-07-05 | 2020-01-09 | Incyte Corporation | Fused pyrazine derivatives as a2a / a2b inhibitors |
-
2021
- 2021-03-25 KR KR1020227037225A patent/KR20230049580A/ko active Pending
- 2021-03-25 CN CN202180038087.XA patent/CN115867550B/zh active Active
- 2021-03-25 AU AU2021241886A patent/AU2021241886A1/en active Pending
- 2021-03-25 US US17/914,157 patent/US12552799B2/en active Active
- 2021-03-25 WO PCT/EP2021/057808 patent/WO2021191380A1/en not_active Ceased
- 2021-03-25 JP JP2022558348A patent/JP7709454B2/ja active Active
- 2021-03-25 EP EP21715554.8A patent/EP4126871B1/en active Active
- 2021-03-25 CA CA3177057A patent/CA3177057A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112513050B (zh) | 抑制shp2活性的杂环化合物 | |
| ES2967457T3 (es) | Inhibidores de PRMT5 | |
| JP2019510798A5 (https=) | ||
| JP5129812B2 (ja) | ビシクロアニリン誘導体 | |
| KR20210097144A (ko) | 피리미딘 및 5-원 질소 헤테로사이클 유도체, 이의 제조 방법, 및 이의 의학적 용도 | |
| WO2021130731A1 (en) | Substituted tricyclic compounds | |
| AU2012204982B2 (en) | 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors | |
| KR102346508B1 (ko) | 키나제 억제제로서 유용한 치환된 테트라히드로카르바졸 및 카르바졸 카르복스아미드 화합물 | |
| KR102345381B1 (ko) | 키나제 억제제로서 유용한 카르바졸 카르복스아미드 화합물 | |
| KR102514914B1 (ko) | 카르바졸 유도체 | |
| JP7237017B2 (ja) | オートファジーモジュレーターとして使用される化合物、ならびにその調製方法および使用 | |
| KR20180015255A (ko) | Hpk1 억제제 및 이의 사용 방법 | |
| CN105732637B (zh) | 杂芳化合物及其在药物中的应用 | |
| AU2016333508A1 (en) | New pyrrolo[2,3-d]pyrimidine derivatives as dual DYRK1/CLK1 inhibitors | |
| JP2023519363A5 (https=) | ||
| AU2020288273B2 (en) | Tricyclic compounds and their use | |
| CN116940563A (zh) | Cdk抑制剂及其作为药物的用途 | |
| JP2023539985A5 (https=) | ||
| JP2013516399A (ja) | キナーゼ阻害剤としての使用のための三環式化合物 | |
| CA3191362A1 (en) | Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof | |
| CA2619897A1 (fr) | Nouveaux derives tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| JP2025517629A (ja) | 複素環式化合物、その組成物、及びそれを用いた治療方法 | |
| AR055321A1 (es) | Compuestos de imidazopiridina uso para a fabricacion de un medicamento para el tratamiento o profilaxis de enfermedades o trastornos en los que se requiere un antagonista de una bomba de acido y composicion farmaceutica que lo comprende | |
| EP4382511A1 (en) | Pyrimidine or pyridine derivative, preparation method therefor, and application thereof in pharmacy | |
| JP2022534501A (ja) | 三環式化合物 |